Condensed consolidating financial statements (Tables)

9 Months Ended

Sep. 30, 2016

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Condensed Consolidating Statements of Income

							Non-
				Guarantor			Guarantor			Consolidating			Consolidated
For the three months ended September 30, 2016	DaVita Inc.			subsidiaries			subsidiaries			adjustments			total
Patient services revenues	$	—		$	1,726,892		$	945,659		$	(42,890	)	$	2,629,661
Less: Provision for uncollectible accounts		—			(73,833	)		(41,722	)		—			(115,555	)
Net patient service revenues		—			1,653,059			903,937			(42,890	)		2,514,106
Capitated revenues		—			462,436			406,894			(40	)		869,290
Other revenues		191,815			509,867			46,185			(400,687	)		347,180
Total net revenues		191,815			2,625,362			1,357,016			(443,617	)		3,730,576
Operating expenses and charges		143,784			2,388,114			823,139			(443,617	)		2,911,420
Operating income		48,031			237,248			533,877			—			819,156
Debt (expense) and refinancing charges		(101,895	)		(91,716	)		(14,402	)		103,432			(104,581	)
Other income, net		99,446			2,659			3,203			(103,432	)		1,876
Income tax expense		(20,898	)		(21,486	)		146,685			—			104,301
Equity earnings in subsidiaries		504,852			335,175			—			(840,027	)		—
Net income		571,332			504,852			375,993			(840,027	)		612,150
Less: Net income attributable to noncontrolling interests		—			—			—			(40,818	)		(40,818	)
Net income attributable to DaVita Inc.	$	571,332		$	504,852		$	375,993		$	(880,845	)	$	571,332

							Non-
				Guarantor			Guarantor			Consolidating			Consolidated
For the three months ended September 30, 2015	DaVita Inc.			subsidiaries			subsidiaries			adjustments			total
Patient service revenues	$	—		$	1,656,648		$	795,325		$	(37,939	)	$	2,414,034
Less: Provision for uncollectible accounts		—			(78,494	)		(30,958	)		—			(109,452	)
Net patient service revenues		—			1,578,154			764,367			(37,939	)		2,304,582
Capitated revenues		—			453,766			473,196			(115	)		926,847
Other revenues		184,561			480,412			7,869			(378,606	)		294,236
Total net revenues		184,561			2,512,332			1,245,432			(416,660	)		3,525,665
Operating expenses		110,935			2,244,237			1,077,785			(416,660	)		3,016,297
Operating income		73,626			268,095			167,647			—			509,368
Debt expense, including debt redemption charges		(102,136	)		(83,037	)		(9,766	)		91,458			(103,481	)
Other income		89,824			2,379			1,739			(91,458	)		2,484
Income tax expense		25,368			112,310			9,386			—			147,064
Equity earnings in subsidiaries		179,926			104,799			—			(284,725	)		—
Net income		215,872			179,926			150,234			(284,725	)		261,307
Less: Net income attributable to noncontrolling interests		—			—			—			(45,435	)		(45,435	)
Net income attributable to DaVita Inc.	$	215,872		$	179,926		$	150,234		$	(330,160	)	$	215,872

							Non-
				Guarantor			Guarantor			Consolidating			Consolidated
For the nine months ended September 30, 2016	DaVita Inc.			subsidiaries			subsidiaries			adjustments			total
Patient services revenues	$	—		$	5,044,565		$	2,756,588		$	(123,100	)	$	7,678,053
Less: Provision for uncollectible accounts		—			(207,144	)		(129,044	)		—			(336,188	)
Net patient service revenues		—			4,837,421			2,627,544			(123,100	)		7,341,865
Capitated revenues		—			1,391,010			1,263,404			(251	)		2,654,163
Other revenues		575,700			1,518,407			122,509			(1,183,281	)		1,033,335
Total net revenues		575,700			7,746,838			4,013,457			(1,306,632	)		11,029,363
Operating expenses and charges		400,129			7,275,863			3,146,888			(1,306,632	)		9,516,248
Operating income		175,571			470,975			866,569			—			1,513,115
Debt (expense) and refinancing charges		(305,097	)		(275,148	)		(38,914	)		308,800			(310,359	)
Other income, net		296,660			12,416			7,791			(308,800	)		8,067
Income tax expense		56,190			140,972			168,849			—			366,011
Equity earnings in subsidiaries		611,204			543,933			—			(1,155,137	)		—
Net income		722,148			611,204			666,597			(1,155,137	)		844,812
Less: Net income attributable to noncontrolling interests		—			—			—			(122,664	)		(122,664	)
Net income attributable to DaVita Inc.	$	722,148		$	611,204		$	666,597		$	(1,277,801	)	$	722,148

							Non-
				Guarantor			Guarantor			Consolidating			Consolidated
For the nine months ended September 30, 2015	DaVita Inc.			subsidiaries			subsidiaries			adjustments			total
Patient service revenues	$	—		$	4,901,959		$	2,254,624		$	(107,155	)	$	7,049,428
Less: Provision for uncollectible accounts		—			(212,816	)		(101,765	)		—			(314,581	)
Net patient service revenues		—			4,689,143			2,152,859			(107,155	)		6,734,847
Capitated revenues		—			1,340,838			1,302,862			(148	)		2,643,552
Other revenues		542,412			1,360,261			21,547			(1,054,371	)		869,849
Total net revenues		542,412			7,390,242			3,477,268			(1,161,674	)		10,248,248
Operating expenses		363,347			7,042,896			3,077,919			(1,161,674	)		9,322,488
Operating income		179,065			347,346			399,349			—			925,760
Debt expense, including debt redemption charges		(347,719	)		(253,939	)		(30,532	)		278,997			(353,193	)
Other income		271,847			6,780			4,632			(278,997	)		4,262
Income tax expense		41,215			116,934			25,744			—			183,893
Equity earnings in subsidiaries		213,754			230,501			—			(444,255	)		—
Net income		275,732			213,754			347,705			(444,255	)		392,936
Less: Net income attributable to noncontrolling interests		—			—			—			(117,204	)		(117,204	)
Net income attributable to DaVita Inc.	$	275,732		$	213,754		$	347,705		$	(561,459	)	$	275,732

Condensed Consolidating Statements of Comprehensive Income

					Non-
			Guarantor		Guarantor		Consolidating			Consolidated
For the three months ended September 30, 2016	DaVita Inc.		subsidiaries		subsidiaries		adjustments			total
Net income	$	571,332	$	504,852	$	375,993	$	(840,027	)	$	612,150
Other comprehensive income		1,248		—		6,620		—			7,868
Total comprehensive income		572,580		504,852		382,613		(840,027	)		620,018
Less: Comprehensive income attributable to noncontrolling interest		—		—		—		(40,876	)		(40,876	)
Comprehensive income attributable to DaVita Inc.	$	572,580	$	504,852	$	382,613	$	(880,903	)	$	579,142

						Non-
				Guarantor		Guarantor			Consolidating			Consolidated
For the three months ended September 30, 2015	DaVita Inc.			subsidiaries		subsidiaries			adjustments			total
Net income	$	215,872		$	179,926	$	150,234		$	(284,725	)	$	261,307
Other comprehensive loss		(2,934	)		—		(7,023	)		—			(9,957	)
Total comprehensive income		212,938			179,926		143,211			(284,725	)		251,350
Less: comprehensive income attributable to the noncontrolling interests		—			—		—			(45,435	)		(45,435	)
Comprehensive income attributable to DaVita Inc.	$	212,938		$	179,926	$	143,211		$	(330,160	)	$	205,915

						Non-
				Guarantor		Guarantor		Consolidating			Consolidated
For the nine months ended September 30, 2016	DaVita Inc.			subsidiaries		subsidiaries		adjustments			total
Net income	$	722,148		$	611,204	$	666,597	$	(1,155,137	)	$	844,812
Other comprehensive loss		(5,299	)		—		13,106		—			7,807
Total comprehensive income		716,849			611,204		679,703		(1,155,137	)		852,619
Less: Comprehensive income attributable to noncontrolling interest		—			—		—		(122,871	)		(122,871	)
Comprehensive income attributable to DaVita Inc.	$	716,849		$	611,204	$	679,703	$	(1,278,008	)	$	729,748

						Non-
				Guarantor		Guarantor			Consolidating			Consolidated
For the nine months ended September 30, 2015	DaVita Inc.			subsidiaries		subsidiaries			adjustments			total
Net income	$	275,732		$	213,754	$	347,705		$	(444,255	)	$	392,936
Other comprehensive loss		(9,436	)		—		(19,883	)		—			(29,319	)
Total comprehensive income		266,296			213,754		327,822			(444,255	)		363,617
Less: comprehensive income attributable to the noncontrolling interests		—			—		—			(117,204	)		(117,204	)
Comprehensive income attributable to DaVita Inc.	$	266,296		$	213,754	$	327,822		$	(561,459	)	$	246,413

Condensed Consolidating Balance Sheets

					Non-
			Guarantor		Guarantor		Consolidating			Consolidated
As of September 30, 2016	DaVita Inc.		subsidiaries		subsidiaries		adjustments			total
Cash and cash equivalents	$	623,901	$	35,769	$	253,826	$	—		$	913,496
Accounts receivable, net		—		1,174,364		676,061		—			1,850,425
Other current assets		661,642		745,238		90,558		—			1,497,438
Total current assets		1,285,543		1,955,371		1,020,445		—			4,261,359
Property and equipment, net		298,869		1,624,181		1,121,938		—			3,044,988
Intangible assets, net		553		1,537,645		37,959		—			1,576,157
Investments in subsidiaries		9,628,258		1,924,432		—		(11,552,690	)		—
Intercompany receivables		3,131,796		—		820,536		(3,952,332	)		—
Other long-term assets and investments		40,574		55,069		564,510		—			660,153
Goodwill		—		7,876,067		1,506,929		—			9,382,996
Total assets	$	14,385,593	$	14,972,765	$	5,072,317	$	(15,505,022	)	$	18,925,653
Current liabilities	$	274,520	$	1,842,058	$	522,891	$	—		$	2,639,469
Intercompany payables		—		2,264,044		1,688,288		(3,952,332	)		—
Long-term debt and other long-term liabilities		8,589,682		1,238,405		366,962		—			10,195,049
Noncontrolling interests subject to put provisions		609,645		—		—		362,099			971,744
Total DaVita Inc. shareholder's equity		4,911,746		9,628,258		1,924,432		(11,552,690	)		4,911,746
Noncontrolling interests not subject to put provisions		—		—		569,744		(362,099	)		207,645
Total equity		4,911,746		9,628,258		2,494,176		(11,914,789	)		5,119,391
Total liabilities and equity	$	14,385,593	$	14,972,765	$	5,072,317	$	(15,505,022	)	$	18,925,653

					Non-
			Guarantor		Guarantor		Consolidating			Consolidated
As of December 31, 2015	DaVita Inc.		subsidiaries		subsidiaries		adjustments			total
Cash and cash equivalents	$	1,186,636	$	109,357	$	203,123	$	—		$	1,499,116
Accounts receivable, net		—		929,390		794,838		—			1,724,228
Other current assets		431,504		769,947		78,485		—			1,279,936
Total current assets		1,618,140		1,808,694		1,076,446		—			4,503,280
Property and equipment, net		268,066		1,575,890		944,784		—			2,788,740
Intangible assets, net		540		1,634,920		51,866		—			1,687,326
Investments in subsidiaries		8,893,079		1,597,185		—		(10,490,264	)		—
Intercompany receivables		3,474,133		—		701,814		(4,175,947	)		—
Other long-term assets and investments		74,458		53,346		113,246		—			241,050
Goodwill		—		7,834,257		1,460,222		—			9,294,479
Total assets	$	14,328,416	$	14,504,292	$	4,348,378	$	(14,666,211	)	$	18,514,875
Current liabilities	$	185,217	$	1,730,123	$	483,798	$	—		$	2,399,138
Intercompany payables		—		2,750,102		1,425,845		(4,175,947	)		—
Long-term debt and other long-term liabilities		8,730,673		1,130,988		305,838		—			10,167,499
Noncontrolling interests subject to put provisions		541,746		—		—		322,320			864,066
Total DaVita Inc. shareholders’ equity		4,870,780		8,893,079		1,597,185		(10,490,264	)		4,870,780
Noncontrolling interests not subject to put provisions		—		—		535,712		(322,320	)		213,392
Total equity		4,870,780		8,893,079		2,132,897		(10,812,584	)		5,084,172
Total liabilities and equity	$	14,328,416	$	14,504,292	$	4,348,378	$	(14,666,211	)	$	18,514,875

Condensed Consolidating Statements of Cash Flows

							Non-
				Guarantor			Guarantor			Consolidating			Consolidated
For the nine months ended September 30, 2016	DaVita Inc.			subsidiaries			subsidiaries			adjustments			total
Cash flows from operating activities:
Net income	$	722,148		$	611,204		$	666,597		$	(1,155,137	)	$	844,812
Changes in operating assets and liabilities and non-cash items included in net income		(586,804	)		228,991			(160,874	)		1,155,137			636,450
Net cash provided by operating activities		135,344			840,195			505,723			—			1,481,262
Cash flows from investing activities:
Additions of property and equipment, net		(81,785	)		(248,339	)		(245,119	)		—			(575,243	)
Acquisitions		—			(458,556	)		(38,775	)		—			(497,331	)
Proceeds from asset and business sales		—			24,608			(5,617	)		—			18,991
(Purchases) proceeds from investment sales and other items, net		(236,150	)		(12,825	)		45,316			—			(203,659	)
Net cash used in investing activities		(317,935	)		(695,112	)		(244,195	)		—			(1,257,242	)
Cash flows from financing activities:
Long-term debt and related financing costs, net		(73,889	)		(20,684	)		(4,151	)		—			(98,724	)
Intercompany borrowing (payments)		283,709			(188,247	)		(95,462	)		—			—
Other items		(589,964	)		(9,740	)		(109,548	)		—			(709,252	)
Net cash (used in) provided by financing activities		(380,144	)		(218,671	)		(209,161	)		—			(807,976	)
Effect of exchange rate changes on cash		—			—			(1,664	)		—			(1,664	)
Net (decrease) increase in cash and cash equivalents		(562,735	)		(73,588	)		50,703			—			(585,620	)
Cash and cash equivalents at beginning of period		1,186,636			109,357			203,123			—			1,499,116
Cash and cash equivalents at end of period	$	623,901		$	35,769		$	253,826		$	—		$	913,496

							Non-
				Guarantor			Guarantor			Consolidating			Consolidated
For the nine months ended September 30, 2015	DaVita Inc.			subsidiaries			subsidiaries			adjustments			total
Cash flows from operating activities:
Net income	$	275,732		$	213,754		$	347,705		$	(444,255	)	$	392,936
Changes in operating assets and liabilities and non-cash items included in net income		(187,876	)		441,752			29,460			444,255			727,591
Net cash provided by operating activities		87,856			655,506			377,165			—			1,120,527
Cash flows from investing activities:
Additions of property and equipment, net		(39,448	)		(222,447	)		(200,318	)		—			(462,213	)
Acquisitions		—			(73,339	)		(17,370	)		—			(90,709	)
Proceeds from asset and business sales		—			6,865			—			—			6,865
(Purchases) proceeds from investment sales and other items, net		(587,583	)		1,513			(18,257	)		—			(604,327	)
Net cash used in investing activities		(627,031	)		(287,408	)		(235,945	)		—			(1,150,384	)
Cash flows from financing activities:
Long-term debt and related financing costs, net		661,260			(13,183	)		(8,760	)		—			639,317
Intercompany borrowing (payments)		304,623			(320,262	)		15,639			—			—
Other items		(404,107	)		(23,605	)		(97,726	)		—			(525,438	)
Net cash provided by (used in) financing activities		561,776			(357,050	)		(90,847	)		—			113,879
Effect of exchange rate changes on cash		—			—			(1,844	)		—			(1,844	)
Net increase in cash and cash equivalents		22,601			11,048			48,529			—			82,178
Cash and cash equivalents at beginning of period		698,876			77,921			188,444			—			965,241
Cash and cash equivalents at end of period	$	721,477		$	88,969		$	236,973		$	—		$	1,047,419